<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39138793</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-024-01290-1</ELocationID><Abstract><AbstractText>The aging population in Europe faces a substantial burden from dementia, with vascular cognitive impairment and dementia (VCID) being a preventable cause. Atrial fibrillation (AF), a common cardiac arrhythmia, increases the risk of VCID through mechanisms such as thromboembolism, cerebral hypoperfusion, and inflammation. This review explores the epidemiology, pathophysiology, and preventive strategies for AF-related VCID. Epidemiological data indicate that AF prevalence rises with age, affecting up to 12% of individuals over 80. Neuroimaging studies reveal chronic brain changes in AF patients, including strokes, lacunar strokes, white matter hyperintensities (WMHs), and cerebral microbleeds (CMHs), while cognitive assessments show impairments in memory, executive function, and attention. The COVID-19 pandemic has exacerbated the underdiagnosis of AF, leading to an increase in undiagnosed strokes and cognitive impairment. Many elderly individuals did not seek medical care due to fear of exposure, resulting in delayed diagnoses. Additionally, reduced family supervision during the pandemic contributed to missed opportunities for early detection of AF and related complications. Emerging evidence suggests that long COVID may also elevate the risk of AF, further complicating the management of this condition. This review underscores the importance of early detection and comprehensive management of AF to mitigate cognitive decline. Preventive measures, including public awareness campaigns, patient education, and the use of smart devices for early detection, are crucial. Anticoagulation therapy, rate and rhythm control, and addressing comorbid conditions are essential therapeutic strategies. Recognizing and addressing the cardiovascular and cognitive impacts of AF, especially in the context of the COVID-19 pandemic, is essential for advancing public health.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fekete</LastName><ForeName>M&#xf3;nika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liotta</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Doctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molnar</LastName><ForeName>Tihamer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical School, University of Pecs, Pecs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>F&#xfc;l&#xf6;p</LastName><ForeName>G&#xe1;bor A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehoczki</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4285-7518</Identifier><AffiliationInfo><Affiliation>Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary. andrea.m.lehoczki@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary. andrea.m.lehoczki@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RRF-2.3.1-21-2022-00003</GrantID><Agency>Nemzeti Kutat&#xe1;si, Fejleszt&#xe9;si &#xe9;s Innovaci&#xf3;s Alap</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Emboli</Keyword><Keyword MajorTopicYN="N">VCI</Keyword><Keyword MajorTopicYN="N">VCID</Keyword><Keyword MajorTopicYN="N">Vascular cognitive impairment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39138793</ArticleId><ArticleId IdType="doi">10.1007/s11357-024-01290-1</ArticleId><ArticleId IdType="pii">10.1007/s11357-024-01290-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eurostat: Aging Europe. https://ec.europa.eu/eurostat/cache/digpub/ageing/ . Accessed 4 Nov 2022.</Citation></Reference><Reference><Citation>GBD. Dementia forecasting collaborators: estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2019;2022(7):e105&#x2013;25. https://doi.org/10.1016/S2468-2667(21)00249-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00249-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11:157&#x2013;65. https://doi.org/10.1038/nrneurol.2015.10 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.10</ArticleId><ArticleId IdType="pubmed">25686760</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413&#x2013;46. https://doi.org/10.1016/S0140-6736(20)30367-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId><ArticleId IdType="pmc">7392084</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019;73:3326&#x2013;44. https://doi.org/10.1016/j.jacc.2019.04.034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.04.034</ArticleId><ArticleId IdType="pubmed">31248555</ArticleId><ArticleId IdType="pmc">6719789</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368:1326&#x2013;34. https://doi.org/10.1056/NEJMsa1204629 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1204629</ArticleId><ArticleId IdType="pubmed">23550670</ArticleId><ArticleId IdType="pmc">3959992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelick PB, Counts SE, Nyenhuis D. Vascular cognitive impairment and dementia. Biochim Biophys Acta. 2016;1862:860&#x2013;8. https://doi.org/10.1016/j.bbadis.2015.12.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.12.015</ArticleId><ArticleId IdType="pubmed">26704177</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Brink H, Doubal FN, Duering M. Advanced MRI in cerebral small vessel disease. Int J Stroke. 2023;18:28&#x2013;35. https://doi.org/10.1177/17474930221091879 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17474930221091879</ArticleId><ArticleId IdType="pubmed">35311609</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi FM, Wang MM, Meschia JF. Cerebral small vessel disease-related dementia: more questions than answers. Stroke. 2023;54:648&#x2013;60. https://doi.org/10.1161/STROKEAHA.122.038265 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.122.038265</ArticleId><ArticleId IdType="pubmed">36848423</ArticleId><ArticleId IdType="pmc">10357466</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus HS, van Der Flier WM, Smith EE, Bath P, Biessels GJ, Briceno E, Brodtman A, Chabriat H, Chen C, de Leeuw FE, et al. Framework for clinical trials in cerebral small vessel disease (FINESSE): a review. JAMA Neurol. 2022;79:1187&#x2013;98. https://doi.org/10.1001/jamaneurol.2022.2262 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.2262</ArticleId><ArticleId IdType="pubmed">35969390</ArticleId><ArticleId IdType="pmc">11036410</ArticleId></ArticleIdList></Reference><Reference><Citation>De Silva TM, Faraci FM. Contributions of aging to cerebral small vessel disease. Annu Rev Physiol. 2020;82:275&#x2013;95. https://doi.org/10.1146/annurev-physiol-021119-034338 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-021119-034338</ArticleId><ArticleId IdType="pubmed">31618600</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva R, Miranda CM, Liu T, Tse G, Roever L. Atrial fibrillation and risk of dementia: epidemiology, mechanisms, and effect of anticoagulation. Front Neurosci. 2019;13:18. https://doi.org/10.3389/fnins.2019.00018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00018</ArticleId><ArticleId IdType="pubmed">30766470</ArticleId><ArticleId IdType="pmc">6365433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wandell P, Carlsson AC, Sundquist J, Sundquist K. The association between relevant comorbidities and dementia in patients with atrial fibrillation. Geroscience. 2018. https://doi.org/10.1007/s11357-018-0029-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-018-0029-8</ArticleId><ArticleId IdType="pubmed">29934733</ArticleId><ArticleId IdType="pmc">6060202</ArticleId></ArticleIdList></Reference><Reference><Citation>Friberg L, Rosenqvist M. Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J. 2018;39:453&#x2013;60. https://doi.org/10.1093/eurheartj/ehx579 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx579</ArticleId><ArticleId IdType="pubmed">29077849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai Y, Hu F, Yuan L, Ye X, Shi W, Yang R, Cao Y, Sun J, He J, Xu F. Atrial fibrillation increases the risk of all-cause dementia, Alzheimer&#x2019;s disease, and vascular dementia: a cohort study of 373, 415 participants in the UK Biobank. J Affect Disord. 2024;351:323&#x2013;30. https://doi.org/10.1016/j.jad.2024.01.224 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2024.01.224</ArticleId><ArticleId IdType="pubmed">38286227</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks K, Yoshimura H, Gonzalez-Izquierdo A, Zakkak N, Kukendra-Rajah K, Lip GYH, Providencia R. The association between atrial fibrillation and dementia: a UK linked electronic health records cohort study. Eur J Clin Invest. 2024;54:e14154. https://doi.org/10.1111/eci.14154 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.14154</ArticleId><ArticleId IdType="pubmed">38217524</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal N, Zelnick LR, An J, Harrison TN, Lee MS, Singer DE, Fan D, Go AS. Incident atrial fibrillation and risk of dementia in a diverse, community-based population. J Am Heart Assoc. 2023;12:e028290. https://doi.org/10.1161/JAHA.122.028290 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.028290</ArticleId><ArticleId IdType="pubmed">36883422</ArticleId><ArticleId IdType="pmc">10111519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivard L, Friberg L, Conen D, Healey JS, Berge T, Boriani G, Brandes A, Calkins H, Camm AJ, Yee Chen L, et al. Atrial fibrillation and dementia: a report from the AF-SCREEN international collaboration. Circulation. 2022;145:392&#x2013;409. https://doi.org/10.1161/CIRCULATIONAHA.121.055018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.055018</ArticleId><ArticleId IdType="pubmed">35100023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai SW. Atrial fibrillation and the risk of dementia. Am J Geriatr Psychiatry. 2022;30:117. https://doi.org/10.1016/j.jagp.2021.07.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2021.07.001</ArticleId><ArticleId IdType="pubmed">34315646</ArticleId></ArticleIdList></Reference><Reference><Citation>Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534&#x2013;9. https://doi.org/10.1016/j.amjcard.2009.07.022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2009.07.022</ArticleId><ArticleId IdType="pubmed">19932788</ArticleId></ArticleIdList></Reference><Reference><Citation>Spannella F, Giulietti F, Pimpini L, Lombardi FE, Re S, Schiavi P, Dragano G, Antonicelli R, Sarzani R. Prevalence and predictors of subclinical atrial fibrillation in hospitalized older adults. Aging (Albany NY). 2021;13:17024&#x2013;37. https://doi.org/10.18632/aging.203270 .</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203270</ArticleId><ArticleId IdType="pubmed">34198265</ArticleId></ArticleIdList></Reference><Reference><Citation>Shkolnikova MA, Jdanov DA, Ildarova RA, Shcherbakova NV, Polyakova EB, Mikhaylov EN, Shalnova SA, Shkolnikov VM. Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study. J Geriatr Cardiol. 2020;17:74&#x2013;84. https://doi.org/10.11909/j.issn.1671-5411.2020.02.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2020.02.002</ArticleId><ArticleId IdType="pubmed">32165880</ArticleId><ArticleId IdType="pmc">7051868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie LA, Oke OB, Harrison SL, Rodgers SE, Lip GYH, Lane DA. Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review. Age Ageing. 2021;50:744&#x2013;57. https://doi.org/10.1093/ageing/afaa268 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa268</ArticleId><ArticleId IdType="pubmed">33951148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie LA, Harrison SL, Penson PE, Akbari A, Torabi F, Hollinghurst J, Harris D, Oke OB, Akpan A, Halcox JP, et al. Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003&#x2013;2018. Age Ageing. 2022;51. https://doi.org/10.1093/ageing/afac252 .</Citation></Reference><Reference><Citation>Lindberg T, Wimo A, Elmstahl S, Qiu C, Bohman DM, Sanmartin BJ. Prevalence and incidence of atrial fibrillation and other arrhythmias in the general older population: findings from the Swedish national study on aging and care. Gerontol Geriatr Med. 2019;5:2333721419859687. https://doi.org/10.1177/2333721419859687 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2333721419859687</ArticleId><ArticleId IdType="pubmed">31276022</ArticleId><ArticleId IdType="pmc">6598326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjerpeseth LJ, Igland J, Selmer R, Ellekjaer H, Tveit A, Berge T, Kalsto SM, Christophersen IE, Myrstad M, Skovlund E, et al. Prevalence and incidence rates of atrial fibrillation in Norway 2004&#x2013;2014. Heart. 2021;107:201&#x2013;7. https://doi.org/10.1136/heartjnl-2020-316624 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-316624</ArticleId><ArticleId IdType="pubmed">32820014</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph PG, Healey JS, Raina P, Connolly SJ, Ibrahim Q, Gupta R, Avezum A, Dans AL, Lopez-Jaramillo P, Yeates K, et al. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals. Cardiovasc Res. 2021;117:1523&#x2013;31. https://doi.org/10.1093/cvr/cvaa241 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa241</ArticleId><ArticleId IdType="pubmed">32777820</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Vinayagamoorthy M, Gencer B, Ng C, Pester J, Cook NR, Lee IM, Buring J, Manson JE, Albert CM. Sex differences in atrial fibrillation risk: the VITAL rhythm study. JAMA Cardiol. 2022;7:1027&#x2013;35. https://doi.org/10.1001/jamacardio.2022.2825 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.2825</ArticleId><ArticleId IdType="pubmed">36044209</ArticleId><ArticleId IdType="pmc">9434484</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YT, Chen YL, Kang HY. Revealing the influences of sex hormones and sex differences in atrial fibrillation and vascular cognitive impairment. Int J Mol Sci. 2021;22(16):8776. https://doi.org/10.3390/ijms22168776 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168776</ArticleId><ArticleId IdType="pubmed">34445515</ArticleId><ArticleId IdType="pmc">8396287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose A, O&#x2019;Neal WT, Wu C, McClure LA, Judd SE, Howard VJ, Howard G, Soliman EZ. Sex differences in risk factors for incident atrial fibrillation (from the reasons for geographic and racial differences in stroke [REGARDS] study). Am J Cardiol. 2019;123:1453&#x2013;7. https://doi.org/10.1016/j.amjcard.2019.01.056 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.01.056</ArticleId><ArticleId IdType="pubmed">30771859</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen F, Uleberg B, Jacobsen BK, Heuch I, Tande PM, Bugge E, Balteskard L. Socioeconomic and geographic differences in ablation of atrial fibrillation in Norway - a national cohort study. BMC Public Health. 2022;22:303. https://doi.org/10.1186/s12889-022-12628-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-12628-9</ArticleId><ArticleId IdType="pubmed">35164725</ArticleId><ArticleId IdType="pmc">8842863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, Howard VJ, Muntner P. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol. 2011;108:227&#x2013;32. https://doi.org/10.1016/j.amjcard.2011.03.026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2011.03.026</ArticleId><ArticleId IdType="pubmed">21530935</ArticleId><ArticleId IdType="pmc">3659169</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman EZ, Howard G, Meschia JF, Cushman M, Muntner P, Pullicino PM, McClure LA, Judd S, Howard VJ. Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2011;42:2950&#x2013;3. https://doi.org/10.1161/STROKEAHA.111.621367 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.621367</ArticleId><ArticleId IdType="pubmed">21817138</ArticleId><ArticleId IdType="pmc">3185239</ArticleId></ArticleIdList></Reference><Reference><Citation>Meschia JF, Merrill P, Soliman EZ, Howard VJ, Barrett KM, Zakai NA, Kleindorfer D, Safford M, Howard G. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2010;41:581&#x2013;7. https://doi.org/10.1161/STROKEAHA.109.573907 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.573907</ArticleId><ArticleId IdType="pubmed">20190000</ArticleId><ArticleId IdType="pmc">2885129</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenancia C, Garnier F, Fichot M, Sagnard A, Laurent G, Lorgis L. Silent atrial fibrillation: clinical management and perspectives. Future Cardiol. 2020;16:133&#x2013;42. https://doi.org/10.2217/fca-2019-0066 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca-2019-0066</ArticleId><ArticleId IdType="pubmed">32125174</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrega K, Lip GYH, Sredniawa B, Sokal A, Streb W, Przyludzki K, Zdrojewski T, Wierucki L, Rutkowski M, Bandosz P, et al. Predicting silent atrial fibrillation in the elderly: a report from the NOMED-AF cross-sectional study. J Clin Med. 2021;10. https://doi.org/10.3390/jcm10112321 .</Citation></Reference><Reference><Citation>Kashou AH, Adedinsewo DA, Noseworthy PA. Subclinical atrial fibrillation: a silent threat with uncertain implications. Annu Rev Med. 2022;73:355&#x2013;62. https://doi.org/10.1146/annurev-med-042420-105906 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042420-105906</ArticleId><ArticleId IdType="pubmed">34788544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Pinilla A, Clua-Espuny JL, Satue-Gracia EM, Palleja-Millan M, Martin-Lujan FM, Study-Group P-T. Protocol for a multicentre and prospective follow-up cohort study of early detection of atrial fibrillation, silent stroke and cognitive impairment in high-risk primary care patients: the PREFA-TE study. BMJ Open. 2024;14:e080736. https://doi.org/10.1136/bmjopen-2023-080736 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-080736</ArticleId><ArticleId IdType="pubmed">38373864</ArticleId><ArticleId IdType="pmc">10882295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretzman JP, Tseng AS, Graff-Radford J, Lee HC, Asirvatham SJ, Mielke MM, Knopman DS, Petersen RC, Jack CR Jr, Vemuri P, et al. Silent cerebral infarcts in patients with atrial fibrillation: clinical implications of an imaging-adjusted CHA2DS2-VASc score. Cardiol J. 2022;29:766&#x2013;72. https://doi.org/10.5603/CJ.a2022.0055 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2022.0055</ArticleId><ArticleId IdType="pubmed">35703042</ArticleId><ArticleId IdType="pmc">9550332</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YJ, Bae MH. Screening and diagnosis of atrial fibrillation using wearable devices. Korean J Intern Med. 2024. https://doi.org/10.3904/kjim.2023.521 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2023.521</ArticleId><ArticleId IdType="pubmed">39135522</ArticleId><ArticleId IdType="pmc">11236811</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller M, Hanssen TA, Johansen D, Jakobsen O, Pedersen JE, Aamot Aksetoy IL, Rasmussen TB, Hartvigsen G, Skogen V, Thrane G. Validity of a smartwatch for detecting atrial fibrillation in patients after heart valve surgery: a prospective observational study. Scand Cardiovasc J. 2024;58:2353069. https://doi.org/10.1080/14017431.2024.2353069 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017431.2024.2353069</ArticleId><ArticleId IdType="pubmed">38794854</ArticleId></ArticleIdList></Reference><Reference><Citation>Henson C, Rambaldini B, Freedman B, Carlson B, Parter C, Christie V, Skinner J, Meharg D, Kirwan M, Ward K, et al. Wearables for early detection of atrial fibrillation and timely referral for Indigenous people &gt;/=55 years: mixed-methods protocol. BMJ Open. 2024;14:e077820. https://doi.org/10.1136/bmjopen-2023-077820 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-077820</ArticleId><ArticleId IdType="pubmed">38199631</ArticleId><ArticleId IdType="pmc">10806615</ArticleId></ArticleIdList></Reference><Reference><Citation>Adasuriya G, Barsky A, Kralj-Hans I, Mohan S, Gill S, Chen Z, Jarman J, Jones D, Valli H, Gkoutos GV, et al. Remote monitoring of atrial fibrillation recurrence using mHealth technology (REMOTE-AF). Eur Heart J Digit Health. 2024;5:344&#x2013;55. https://doi.org/10.1093/ehjdh/ztae011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztae011</ArticleId><ArticleId IdType="pubmed">38774381</ArticleId><ArticleId IdType="pmc">11104468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew DS, Li Z, Steinberg BA, O&#x2019;Brien EC, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, Piccini JP. Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices. Circ Arrhythm Electrophysiol. 2022;15:e010304. https://doi.org/10.1161/CIRCEP.121.010304 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.121.010304</ArticleId><ArticleId IdType="pubmed">35089799</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LY, Chung MK, Allen LA, Ezekowitz M, Furie KL, McCabe P, Noseworthy PA, Perez MV, Turakhia MP, American Heart Association Council on Clinical C, et al. Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association. Circulation. 2018;137:e623&#x2013;44. https://doi.org/10.1161/CIR.0000000000000568 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000568</ArticleId><ArticleId IdType="pubmed">29661944</ArticleId><ArticleId IdType="pmc">8463258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashar SK, Han D, Hajeb-Mohammadalipour S, Ding E, Whitcomb C, McManus DD, Chon KH. Atrial fibrillation detection from wrist photoplethysmography signals using smartwatches. Sci Rep. 2019;9:15054. https://doi.org/10.1038/s41598-019-49092-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49092-2</ArticleId><ArticleId IdType="pubmed">31636284</ArticleId><ArticleId IdType="pmc">6803677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study Stroke. 1997;28:316&#x2013;21. https://doi.org/10.1161/01.str.28.2.316 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.28.2.316</ArticleId><ArticleId IdType="pubmed">9040682</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YL, Chen J, Wang HT, Chang YT, Chong SZ, Hsueh S, Chung CM, Lin YS. Sex difference in the risk of dementia in patients with atrial fibrillation. Diagnostics (Basel). 2021;11(5):760. https://doi.org/10.3390/diagnostics11050760 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11050760</ArticleId><ArticleId IdType="pubmed">33922776</ArticleId><ArticleId IdType="pmc">8145027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao IY, Power MC, Mosley T, Jack C Jr, Gottesman RF, Chen LY, Norby FL, Soliman EZ, Alonso A. Association of atrial fibrillation with white matter disease. Stroke. 2019;50:989&#x2013;91. https://doi.org/10.1161/STROKEAHA.118.023386 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.118.023386</ArticleId><ArticleId IdType="pubmed">30879437</ArticleId><ArticleId IdType="pmc">6433530</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwennesen H, Browndyke JN, Wright MC, Fudim M, Daubert JP, Newman MF, Mathew JP, Piccini JP. A pilot study of longitudinal changes in neurocognition, white matter hyperintensities, and cortical thickness in atrial fibrillation patients following catheter ablation vs medical management. Heart Rhythm. 2024;O2(5):122&#x2013;30. https://doi.org/10.1016/j.hroo.2024.01.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hroo.2024.01.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada T. Risk assessment of cerebral microbleeds and white matter hyperintensities in patients with non-valvular atrial fibrillation. J Neurol Sci. 2017;373:249. https://doi.org/10.1016/j.jns.2017.01.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.01.017</ArticleId><ArticleId IdType="pubmed">28131198</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw FE, de Groot JC, Oudkerk M, Kors JA, Hofman A, van Gijn J, Breteler MM. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology. 2000;54:1795&#x2013;801. https://doi.org/10.1212/wnl.54.9.1795 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.54.9.1795</ArticleId><ArticleId IdType="pubmed">10802786</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Anna L, Filippidis FT, Harvey K, Marinescu M, Bentley P, Korompoki E, Veltkamp R. Extent of white matter lesion is associated with early hemorrhagic transformation in acute ischemic stroke related to atrial fibrillation. Brain Behav. 2021;11:e2250. https://doi.org/10.1002/brb3.2250 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2250</ArticleId><ArticleId IdType="pubmed">34124834</ArticleId><ArticleId IdType="pmc">8413731</ArticleId></ArticleIdList></Reference><Reference><Citation>Amberger U, Lippert J, Mujanovic A, Beyeler M, Siepen B, Vynckier J, Scutelnic A, Goeldlin M, Seiffge D, Jung S, et al. Association of chronic covert cerebral infarctions and white matter hyperintensities with atrial fibrillation detection on post-stroke cardiac rhythm monitoring: a cohort study. J Am Heart Assoc. 2022;11:e026962. https://doi.org/10.1161/JAHA.122.026962 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.026962</ArticleId><ArticleId IdType="pubmed">36515235</ArticleId><ArticleId IdType="pmc">9798803</ArticleId></ArticleIdList></Reference><Reference><Citation>Zito M, Muscari A, Marini E, Di Iorio A, Puddu GM, Abate G. Silent lacunar infarcts in elderly patients with chronic non valvular atrial fibrillation. Aging (Milano). 1996;8:341&#x2013;6. https://doi.org/10.1007/BF03339591 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03339591</ArticleId><ArticleId IdType="pubmed">8959236</ArticleId></ArticleIdList></Reference><Reference><Citation>Knecht S, Oelschlager C, Duning T, Lohmann H, Albers J, Stehling C, Heindel W, Breithardt G, Berger K, Ringelstein EB, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J. 2008;29:2125&#x2013;32. https://doi.org/10.1093/eurheartj/ehn341 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn341</ArticleId><ArticleId IdType="pubmed">18667399</ArticleId></ArticleIdList></Reference><Reference><Citation>Goette A, Braun-Dullaeus RC. Atrial fibrillation is associated with impaired cognitive function and hippocampal atrophy: silent cerebral ischaemia vs. Alzheimer&#x2019;s disease? Eur Heart J. 2008;29:2067&#x2013;9. https://doi.org/10.1093/eurheartj/ehn343 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn343</ArticleId><ArticleId IdType="pubmed">18676399</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefansdottir H, Arnar DO, Aspelund T, Sigurdsson S, Jonsdottir MK, Hjaltason H, Launer LJ, Gudnason V. Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts. Stroke. 2013;44:1020&#x2013;5. https://doi.org/10.1161/STROKEAHA.12.679381 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.12.679381</ArticleId><ArticleId IdType="pubmed">23444303</ArticleId><ArticleId IdType="pmc">3632359</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva DS, Coan AC, Avelar WM. Neuropsychological and neuroimaging evidences of cerebral dysfunction in stroke-free patients with atrial fibrillation: a review. J Neurol Sci. 2019;399:172&#x2013;81. https://doi.org/10.1016/j.jns.2019.02.027 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.027</ArticleId><ArticleId IdType="pubmed">30825695</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias MF, Sullivan LM, Elias PK, Vasan RS, D&#x2019;Agostino RB Sr, Seshadri S, Au R, Wolf PA, Benjamin EJ. Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. J Stroke Cerebrovasc Dis. 2006;15:214&#x2013;22. https://doi.org/10.1016/j.jstrokecerebrovasdis.2006.05.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2006.05.009</ArticleId><ArticleId IdType="pubmed">17904078</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball J, Carrington MJ, Stewart S, SAFETY investigators. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart. 2013;99(8):542&#x2013;7. https://doi.org/10.1136/heartjnl-2012-303182 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-303182</ArticleId><ArticleId IdType="pubmed">23315607</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiffge DJ, Cancelloni V, Raber L, Paciaroni M, Metzner A, Kirchhof P, Fischer U, Werring DJ, Shoamanesh A, Caso V. Secondary stroke prevention in people with atrial fibrillation: treatments and trials. Lancet Neurol. 2024;23:404&#x2013;17. https://doi.org/10.1016/S1474-4422(24)00037-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(24)00037-1</ArticleId><ArticleId IdType="pubmed">38508836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam KW, Kwon HM, Lee YS, Won SH, Moon HS, Park JH. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation. Sci Rep. 2024;14:9838. https://doi.org/10.1038/s41598-024-60660-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-60660-z</ArticleId><ArticleId IdType="pubmed">38684879</ArticleId><ArticleId IdType="pmc">11058194</ArticleId></ArticleIdList></Reference><Reference><Citation>Goeldlin MB, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, Fenzl S, Rezny-Kasprzak B, Rohner R, Strbian D, et al. Early vs late anticoagulation in minor, moderate, and major ischemic stroke with atrial fibrillation: post hoc analysis of the ELAN randomized clinical trial. JAMA Neurol. 2024. https://doi.org/10.1001/jamaneurol.2024.1450 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2024.1450</ArticleId><ArticleId IdType="pubmed">38805207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruun-Jensen M, Winther S, Schmidt SE, Moller DC. DARE-ISC model for prediction of 1-year ischaemic stroke risk in the general population and atrial fibrillation patients: a Danish nationwide cohort study. BMJ Open. 2024;14:e076640. https://doi.org/10.1136/bmjopen-2023-076640 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-076640</ArticleId><ArticleId IdType="pubmed">38760046</ArticleId><ArticleId IdType="pmc">11103190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachinski V, Einhaupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C, et al. Preventing dementia by preventing stroke: the Berlin Manifesto. Alzheimers Dement. 2019;15:961&#x2013;84. https://doi.org/10.1016/j.jalz.2019.06.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.06.001</ArticleId><ArticleId IdType="pubmed">31327392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudorovic N. Clinical significance of microembolus detection by transcranial Doppler sonography in cardiovascular clinical conditions. Int J Surg. 2006;4:232&#x2013;41. https://doi.org/10.1016/j.ijsu.2005.12.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2005.12.001</ArticleId><ArticleId IdType="pubmed">17462357</ArticleId></ArticleIdList></Reference><Reference><Citation>Anselmino M, Scarsoglio S, Saglietto A, Gaita F, Ridolfi L. Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment. Sci Rep. 2016;6:28635. https://doi.org/10.1038/srep28635 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28635</ArticleId><ArticleId IdType="pubmed">27334559</ArticleId><ArticleId IdType="pmc">4917883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Tarantini S, Kiss T, Wren JD, Giles CB, Griffin CT, Murfee WL, Pacher P, Csiszar A. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat Rev Cardiol. 2018;15:555&#x2013;65. https://doi.org/10.1038/s41569-018-0030-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0030-z</ArticleId><ArticleId IdType="pubmed">29795441</ArticleId><ArticleId IdType="pmc">6612360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Tarantini S, Sorond F, Merkely B, Csiszar A. Mechanisms of vascular aging, a geroscience perspective: JACC focus seminar. J Am Coll Cardiol. 2020;75:931&#x2013;41. https://doi.org/10.1016/j.jacc.2019.11.061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.11.061</ArticleId><ArticleId IdType="pubmed">32130929</ArticleId><ArticleId IdType="pmc">8559983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849&#x2013;67. https://doi.org/10.1161/CIRCRESAHA.118.311378 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.311378</ArticleId><ArticleId IdType="pubmed">30355080</ArticleId><ArticleId IdType="pmc">6248882</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312:H1&#x2013;20. https://doi.org/10.1152/ajpheart.00581.2016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00581.2016</ArticleId><ArticleId IdType="pubmed">27793855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai Y. Inflammation and atrial fibrillation. J Arrhythm. 2024;40:26&#x2013;7. https://doi.org/10.1002/joa3.12984 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.12984</ArticleId><ArticleId IdType="pubmed">38333377</ArticleId><ArticleId IdType="pmc">10848572</ArticleId></ArticleIdList></Reference><Reference><Citation>Okawa K, Sogo M, Morimoto T, Tsushima R, Sudo Y, Saito E, Ozaki M, Takahashi M. Relationship between endothelial dysfunction and the outcomes after atrial fibrillation ablation. J Am Heart Assoc. 2023;12:e028482. https://doi.org/10.1161/JAHA.122.028482 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.028482</ArticleId><ArticleId IdType="pubmed">37232257</ArticleId><ArticleId IdType="pmc">10381982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke HH, Li J, Liang G, Li S, Wang S, Zhong G. Correlation of oxidative stress and vascular endothelial dysfunction with hippocampal perfusion in atrial fibrillation patients with cognitive impairment. SAGE Open Med. 2024;12:20503121241243250. https://doi.org/10.1177/20503121241243247 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121241243247</ArticleId><ArticleId IdType="pubmed">38601137</ArticleId><ArticleId IdType="pmc">11005482</ArticleId></ArticleIdList></Reference><Reference><Citation>Corban MT, Toya T, Ahmad A, Lerman LO, Lee HC, Lerman A. Atrial fibrillation and endothelial dysfunction: a potential link? Mayo Clin Proc. 2021;96:1609&#x2013;21. https://doi.org/10.1016/j.mayocp.2020.11.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.11.005</ArticleId><ArticleId IdType="pubmed">33775421</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryal R, Patabendige A. Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes? Open Biol. 2021;11:200396. https://doi.org/10.1098/rsob.200396 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200396</ArticleId><ArticleId IdType="pubmed">33878948</ArticleId><ArticleId IdType="pmc">8059575</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21&#x2013;78. https://doi.org/10.1152/physrev.00050.2017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00050.2017</ArticleId><ArticleId IdType="pubmed">30280653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133&#x2013;50. https://doi.org/10.1038/nrneurol.2017.188 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId><ArticleId IdType="pmc">5829048</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Lee SR, Choi EK, Lee H, Chung J, Choi J, Han M, Ahn HJ, Kwon S, Lee SW, et al. Low risk of dementia in patients with newly diagnosed atrial fibrillation and a clustering of healthy lifestyle behaviors: a nationwide population-based cohort study. J Am Heart Assoc. 2022;11:e023739. https://doi.org/10.1161/JAHA.121.023739 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.023739</ArticleId><ArticleId IdType="pubmed">35322686</ArticleId><ArticleId IdType="pmc">9075438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mant J, Modi RN, Dymond A, Armstrong N, Burt J, Calvert P, Cowie M, Ding WY, Edwards D, Freedman B, et al. Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial. BMJ Open. 2024;14:e082047. https://doi.org/10.1136/bmjopen-2023-082047 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-082047</ArticleId><ArticleId IdType="pubmed">38670614</ArticleId><ArticleId IdType="pmc">11057258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford GA, Hargroves D, Lowe D, Hicks N, Lip GYH, Rooney G, Oatley H. Targeted atrial fibrillation detection in COVID-19 vaccination clinics. Eur Heart J Qual Care Clin Outcomes. 2021;7:526&#x2013;8. https://doi.org/10.1093/ehjqcco/qcab061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcab061</ArticleId><ArticleId IdType="pubmed">34448836</ArticleId><ArticleId IdType="pmc">8499813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendelboe AM, Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Ddungu H, Dvorak JD, Hunt BJ, Hylek EM, Kakkar A, et al. Global public awareness about atrial fibrillation. Res Pract Thromb Haemost. 2018;2:49&#x2013;57. https://doi.org/10.1002/rth2.12051 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12051</ArticleId><ArticleId IdType="pubmed">30046706</ArticleId></ArticleIdList></Reference><Reference><Citation>Reading SR, Go AS, Fang MC, Singer DE, Liu IA, Black MH, Udaltsova N, Reynolds K. Anticoagulation, risk factors in atrial fibrillation-cardiovascular research network I. Health literacy and awareness of atrial fibrillation. J Am Heart Assoc. 2017;6(4):e005128. https://doi.org/10.1161/JAHA.116.005128 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.005128</ArticleId><ArticleId IdType="pubmed">28400367</ArticleId><ArticleId IdType="pmc">5533014</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe PJ, Lloyd MPA, Balls-Berry J, Johnson J, LaScotte J, Lee HC. Atrial fibrillation: community screening events improve awareness in older adults. J Gerontol Nurs. 2019;45:31&#x2013;8. https://doi.org/10.3928/00989134-20190813-04 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/00989134-20190813-04</ArticleId><ArticleId IdType="pubmed">31437288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakkireddy D, Natale A. World atrial fibrillation awareness day: creating grassroots level awareness to combat a global scourge. J Atr Fibrillation. 2016;9:1482. https://doi.org/10.4022/jafib.1482 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4022/jafib.1482</ArticleId><ArticleId IdType="pubmed">27909545</ArticleId><ArticleId IdType="pmc">5129698</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs R, Drumm B, Dwyer R, O&#x2019;Neill D, Kennelly SP, Coughlan T, Collins R. Awareness of atrial fibrillation-effectiveness of a pilot national awareness campaign. Ir J Med Sci. 2020;189:149&#x2013;53. https://doi.org/10.1007/s11845-019-02049-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-019-02049-w</ArticleId><ArticleId IdType="pubmed">31256311</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama H, Hasegawa Y. Awareness of atrial fibrillation in Japan: a large-scale, nationwide Internet survey of 50 000 Japanese adults. Geriatr Gerontol Int. 2018;18:1100&#x2013;7. https://doi.org/10.1111/ggi.13318 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.13318</ArticleId><ArticleId IdType="pubmed">29603540</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtanen R, Kryssi V, Vasankari T, Salminen M, Kivela SL, Airaksinen KE. Self-detection of atrial fibrillation in an aged population: the LietoAF study. Eur J Prev Cardiol. 2014;21:1437&#x2013;42. https://doi.org/10.1177/2047487313494041 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487313494041</ArticleId><ArticleId IdType="pubmed">23780517</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaakkola J, Virtanen R, Vasankari T, Salminen M, Airaksinen KEJ. Self-detection of atrial fibrillation in an aged population: three-year follow-up of the LietoAF intervention study. BMC Geriatr. 2017;17:218. https://doi.org/10.1186/s12877-017-0607-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-017-0607-0</ArticleId><ArticleId IdType="pubmed">28915862</ArticleId><ArticleId IdType="pmc">5602855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KC, Kok C, Marschner S, Usherwood T, Chow CK. Screening for atrial fibrillation and other arrhythmias in primary care. BMC Fam Pract. 2020;21:79. https://doi.org/10.1186/s12875-020-01151-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-020-01151-8</ArticleId><ArticleId IdType="pubmed">32375662</ArticleId><ArticleId IdType="pmc">7201749</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen L, Abdalrahim R, Dekker LRC, Thijssen EJM, de Jong S, Polak PE, van de Voort PH, Smits G, Scheele K, Lucas A, et al. Regional implementation of atrial fibrillation screening: benefits and pitfalls. Eur Heart J Digit Health. 2022;3:570&#x2013;7. https://doi.org/10.1093/ehjdh/ztac055 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztac055</ArticleId><ArticleId IdType="pubmed">36710905</ArticleId><ArticleId IdType="pmc">9779812</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A, Okamura T, Sasaki M, Matsuoka H, Ikeda Y, Takahashi A, Akiyama S, Ono F, Yoshihara N, Akita Study Group. Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care. PLoS One. 2020;15:e0244240. https://doi.org/10.1371/journal.pone.0244240 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244240</ArticleId><ArticleId IdType="pubmed">33378380</ArticleId><ArticleId IdType="pmc">7773196</ArticleId></ArticleIdList></Reference><Reference><Citation>Callanan A, Bayat F, Quinlan D, Kearney PM, Buckley CM, Smith SM, Bradley CP. Facilitators and barriers to atrial fibrillation screening in primary care: a qualitative descriptive study of GPs in primary care in the Republic of Ireland. BJGP Open. 2023;7. https://doi.org/10.3399/BJGPO.2022.0110</Citation></Reference><Reference><Citation>Qvist I, Lane DA, Risom SS, Hendriks JM, Hojen AA, Johnsen SP, Frost L. Implementation of patient education for patients with atrial fibrillation: nationwide cross-sectional survey and one-year follow-up. Eur J Cardiovasc Nurs. 2024;23:251&#x2013;7. https://doi.org/10.1093/eurjcn/zvad066 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjcn/zvad066</ArticleId><ArticleId IdType="pubmed">37490762</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihas P, Rosman L, Armbruster T, Walker J, Deyo Z, Gehi A. Assessing a virtual education intervention for patients with atrial fibrillation: a qualitative study of patient perceptions. J Cardiovasc Nurs. 2024;39:E1&#x2013;11. https://doi.org/10.1097/JCN.0000000000000984 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCN.0000000000000984</ArticleId><ArticleId IdType="pubmed">37088903</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Bian L, Jiang L, Liang W, Wu Z. Does YouTube provide qualified patient education videos about atrial fibrillation? Front Public Health. 2022;10:925691. https://doi.org/10.3389/fpubh.2022.925691 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.925691</ArticleId><ArticleId IdType="pubmed">35910923</ArticleId><ArticleId IdType="pmc">9326493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagne M, Legault C, Boulet LP, Charbonneau L, Lemyre M, Giguere AMC, Poirier P. Impact of adding a video to patient education on quality of life among adults with atrial fibrillation: a randomized controlled trial. Patient Educ Couns. 2019;102:1490&#x2013;8. https://doi.org/10.1016/j.pec.2019.03.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2019.03.015</ArticleId><ArticleId IdType="pubmed">30956021</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou P, Dafli E, Giannakoulas G, Igimbayeva G, Visternichan O, Kyselov S, Lykhasenko I, Lashkul D, Nadareishvili I, Tabagari S, Bamidis PD. Education of patients with atrial fibrillation and evaluation of the efficacy of a mobile virtual patient environment: protocol for a multicenter pseudorandomized controlled trial. JMIR Res Protoc. 2024;13:e45946. https://doi.org/10.2196/45946 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/45946</ArticleId><ArticleId IdType="pubmed">38261376</ArticleId><ArticleId IdType="pmc">10848131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding EY, Tran KV, Lessard D, Wang Z, Han D, Mohagheghian F, Mensah Otabil E, Noorishirazi K, Mehawej J, Filippaios A, et al. Accuracy, usability, and adherence of smartwatches for atrial fibrillation detection in older adults after stroke: randomized controlled trial. JMIR Cardio. 2023;7:e45137. https://doi.org/10.2196/45137 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/45137</ArticleId><ArticleId IdType="pubmed">38015598</ArticleId><ArticleId IdType="pmc">10716742</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorr M, Nohturfft V, Brasier N, Bosshard E, Djurdjevic A, Gross S, Raichle CJ, Rhinisperger M, Stockli R, Eckstein J. The WATCH AF trial: SmartWATCHes for detection of atrial fibrillation. JACC Clin Electrophysiol. 2019;5:199&#x2013;208. https://doi.org/10.1016/j.jacep.2018.10.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2018.10.006</ArticleId><ArticleId IdType="pubmed">30784691</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao MT, Yu CC, Lin LY, Pan KH, Tsai TH, Wu YC, Liu YB. Impact of recording length and other arrhythmias on atrial fibrillation detection from wrist photoplethysmogram using smartwatches. Sci Rep. 2022;12:5364. https://doi.org/10.1038/s41598-022-09181-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09181-1</ArticleId><ArticleId IdType="pubmed">35354873</ArticleId><ArticleId IdType="pmc">8967835</ArticleId></ArticleIdList></Reference><Reference><Citation>Mela T. Smartwatches in the fight against atrial fibrillation: the little watch that could. J Am Coll Cardiol. 2018;71:2389&#x2013;91. https://doi.org/10.1016/j.jacc.2018.03.485 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.03.485</ArticleId><ArticleId IdType="pubmed">29793627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuvvula S, Ding EY, Saleeba C, Shi Q, Wang Z, Kapoor A, Saczynski JS, Lubitz SA, Kovell LC, McKee MD, McManus DD. NExUS-Heart: novel examinations using smart technologies for heart health-data sharing from commercial wearable devices and telehealth engagement in participants with or at risk of atrial fibrillation. Cardiovasc Digit Health J. 2021;2:256&#x2013;63. https://doi.org/10.1016/j.cvdhj.2021.08.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2021.08.001</ArticleId><ArticleId IdType="pubmed">35265917</ArticleId><ArticleId IdType="pmc">8890085</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingenheben T, Israel CW. Use of telemedicine in the diagnosis of paroxysmal atrial fibrillation and to monitor the effect of antiarrhythmic drug therapy. Herzschrittmacherther Elektrophysiol. 2006;17:225&#x2013;8. https://doi.org/10.1007/s00399-006-0539-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00399-006-0539-4</ArticleId><ArticleId IdType="pubmed">17211755</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck BH, Hill MD, Quinn FR, Butcher KS, Menon BK, Gulamhusein S, Siddiqui M, Coutts SB, Jeerakathil T, Smith EE, et al. Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the PER DIEM randomized clinical trial. JAMA. 2021;325:2160&#x2013;8. https://doi.org/10.1001/jama.2021.6128 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.6128</ArticleId><ArticleId IdType="pubmed">34061146</ArticleId><ArticleId IdType="pmc">8170545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung SF, Yang HY, Tsai CF, Fang CW. Comparing the risk of dementia in patients with atrial fibrillation taking different oral anticoagulants. Eur J Intern Med. 2024;122:139&#x2013;41. https://doi.org/10.1016/j.ejim.2024.02.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2024.02.008</ArticleId><ArticleId IdType="pubmed">38369447</ArticleId></ArticleIdList></Reference><Reference><Citation>Latif F, Nasir MM, Meer KK, Farhan SH, Cheema HA, Khan AB, Umer M, Rehman WU, Ahmad A, Khan MA, et al. The effect of oral anticoagulants on the incidence of dementia in patients with atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol Cardiovasc Risk Prev. 2024;21:200282. https://doi.org/10.1016/j.ijcrp.2024.200282 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcrp.2024.200282</ArticleId><ArticleId IdType="pubmed">38766665</ArticleId><ArticleId IdType="pmc">11101875</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbone G, Ercolano E, Bencivenga L, Palaia ME, Scognamiglio F, Rengo G, Femminella GD. Atrial fibrillation and dementia: focus on shared pathophysiological mechanisms and therapeutic implications. J Am Med Dir Assoc. 2024;25:465&#x2013;9. https://doi.org/10.1016/j.jamda.2024.01.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2024.01.010</ArticleId><ArticleId IdType="pubmed">38359898</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerstrom F, Charitakis E, Paul-Nordin A, Braunschweig F, Friberg L, Tabrizi F, Jensen-Urstad M, Drca N. Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablation. Heart Rhythm. 2024. https://doi.org/10.1016/j.hrthm.2024.04.038 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2024.04.038</ArticleId><ArticleId IdType="pubmed">38604586</ArticleId></ArticleIdList></Reference><Reference><Citation>Grymonprez M, Petrovic M, De Backer TL, Ikram MA, Steurbaut S, Lahousse L. Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study. Age Ageing. 2023;52(3):afad038. https://doi.org/10.1093/ageing/afad038 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afad038</ArticleId><ArticleId IdType="pubmed">36934339</ArticleId><ArticleId IdType="pmc">10024890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendlebury ST. Direct oral anticoagulants and prevention of dementia in nonvalvular atrial fibrillation. Stroke. 2021;52:3469&#x2013;71. https://doi.org/10.1161/STROKEAHA.121.035664 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.121.035664</ArticleId><ArticleId IdType="pubmed">34496623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SR, Choi EK, Park SH, Jung JH, Han KD, Oh S, Lip GYH. Comparing warfarin and 4 direct oral anticoagulants for the risk of dementia in patients with atrial fibrillation. Stroke. 2021;52:3459&#x2013;68. https://doi.org/10.1161/STROKEAHA.120.033338 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.033338</ArticleId><ArticleId IdType="pubmed">34496627</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly SJ, Healey JS, Belley-Cote EP, Balasubramanian K, Paparella D, Brady K, Reents W, Danner BC, Devereaux PJ, Sharma M, et al. Oral anticoagulation use and left atrial appendage occlusion in LAAOS III. Circulation. 2023;148:1298&#x2013;304. https://doi.org/10.1161/CIRCULATIONAHA.122.060315 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.060315</ArticleId><ArticleId IdType="pubmed">37732457</ArticleId><ArticleId IdType="pmc">10589428</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanc C, Blanc G, Boveda S, Calviere L, Combes N, Viguier A, Mondoly P, Albucher JF, Gollion C, Fabry V, et al. Left atrial appendage closure in patients with atrial fibrillation and coexisting cerebral amyloid angiopathy. Stroke. 2021;52:e792&#x2013;3. https://doi.org/10.1161/STROKEAHA.121.037248 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.121.037248</ArticleId><ArticleId IdType="pubmed">34749507</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag M, Mac Grory B, Nackenoff A, Eaton J, Mistry E, Kirshner H, Yaghi S, Ellis CR. Left atrial appendage closure for patients with cerebral amyloid angiopathy and atrial fibrillation: the LAA-CAA cohort. Transl Stroke Res. 2021;12:259&#x2013;65. https://doi.org/10.1007/s12975-020-00838-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-020-00838-5</ArticleId><ArticleId IdType="pubmed">32770310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J. New horizons: managing antithrombotic dilemmas in patients with cerebral amyloid angiopathy. Age Ageing. 2021;50:347&#x2013;55. https://doi.org/10.1093/ageing/afaa275 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa275</ArticleId><ArticleId IdType="pubmed">33480964</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85:1930&#x2013;6. https://doi.org/10.1212/WNL.0000000000002175 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002175</ArticleId><ArticleId IdType="pubmed">26537052</ArticleId><ArticleId IdType="pmc">4664125</ArticleId></ArticleIdList></Reference><Reference><Citation>Koemans EA, Chhatwal JP, van Veluw SJ, van Etten ES, van Osch MJP, van Walderveen MAA, Sohrabi HR, Kozberg MG, Shirzadi Z, Terwindt GM, et al. Progression of cerebral amyloid angiopathy: a pathophysiological framework. Lancet Neurol. 2023;22:632&#x2013;42. https://doi.org/10.1016/S1474-4422(23)00114-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(23)00114-X</ArticleId><ArticleId IdType="pubmed">37236210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SR, Choi EK, Lee SW, Han KD, Oh S, Lip GY. Early rhythm control and incident dementia in patients with atrial fibrillation and prior stroke. JACC: Clin Electrophysiol. 2024. https://doi.org/10.1016/j.jacep.2024.03.007 .</Citation></Reference><Reference><Citation>Guo J, Liu Y, Jia J, Lu J, Wang D, Zhang J, Ding J, Zhao X. Effects of rhythm-control and rate-control strategies on cognitive function and dementia in atrial fibrillation: a systematic review and meta-analysis. Age Ageing. 2024;53(2):afae009. https://doi.org/10.1093/ageing/afae009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afae009</ArticleId><ArticleId IdType="pubmed">38369630</ArticleId></ArticleIdList></Reference><Reference><Citation>Saka E, Topcuoglu MA. Rhythm control and dementia in patients with atrial fibrillation: a role for glymphatic system? Can J Cardiol. 2023;39:198. https://doi.org/10.1016/j.cjca.2022.11.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.11.016</ArticleId><ArticleId IdType="pubmed">36529402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367:1587&#x2013;95. https://doi.org/10.1056/NEJMoa1113566 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1113566</ArticleId><ArticleId IdType="pubmed">23094720</ArticleId></ArticleIdList></Reference><Reference><Citation>De Becker B, Van de Borne P. Treatment of hypertension to prevent atrial fibrillation. Curr Pharm Des. 2018;24:4397&#x2013;403. https://doi.org/10.2174/1381612825666181127100437 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666181127100437</ArticleId><ArticleId IdType="pubmed">30479208</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumprecht J, Lip GYH, Sokal A, Sredniawa B, Stokwiszewski J, Zdrojewski T, Rutkowski M, Grodzicki T, Kazmierczak J, Opolski G, Kalarus Z. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged &gt;/= 65. Sci Rep. 2023;13:17252. https://doi.org/10.1038/s41598-023-43939-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-43939-5</ArticleId><ArticleId IdType="pubmed">37828071</ArticleId><ArticleId IdType="pmc">10570325</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwafi H, Wong ICK, Banerjee A, Mongkhon P, Whittlesea C, Naser AY, Lau WCY, Wei L. Epidemiology and treatment of atrial fibrillation in patients with type 2 diabetes in the UK, 2001&#x2013;2016. Sci Rep. 2020;10:12468. https://doi.org/10.1038/s41598-020-69492-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69492-z</ArticleId><ArticleId IdType="pubmed">32719438</ArticleId><ArticleId IdType="pmc">7385086</ArticleId></ArticleIdList></Reference><Reference><Citation>Valls-Pedret C, Lamuela-Raventos RM, Medina-Remon A, Quintana M, Corella D, Pinto X, Martinez-Gonzalez MA, Estruch R, Ros E. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J Alzheimers Dis. 2012;29:773&#x2013;82. https://doi.org/10.3233/JAD-2012-111799W012188621153H61[pii] .</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-111799W012188621153H61[pii]</ArticleId><ArticleId IdType="pubmed">22349682</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggi S, Ticinesi A, Limongi F, Noale M, Ecarnot F. The role of nutrition and the Mediterranean diet on the trajectories of cognitive decline. Exp Gerontol. 2023;173:112110. https://doi.org/10.1016/j.exger.2023.112110 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2023.112110</ArticleId><ArticleId IdType="pubmed">36720373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Fazekas-Pongor V, Csiszar A, Kunutsor SK. The multifaceted benefits of walking for healthy aging: from Blue Zones to molecular mechanisms. Geroscience. 2023;45(6):3211&#x2013;39. https://doi.org/10.1007/s11357-023-00873-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-023-00873-8</ArticleId><ArticleId IdType="pubmed">37495893</ArticleId><ArticleId IdType="pmc">10643563</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Szabo Z, Bartha E, Illes Z. &#x201c;Cerebrovascular stressing&#x201d;: dipyridamole-induced S100B elevation predicts ischemic cerebrovascular events. Clin Chem Lab Med. 2013;51:e69-72. https://doi.org/10.1515/cclm-2012-0337 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2012-0337</ArticleId><ArticleId IdType="pubmed">23045382</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Horvath A, Szabo Z, Vamos Z, Doczi T, Illes Z. Detection of silent cerebral microcirculatory abnormalities in patients with manifest ischemic coronary disease: a perfusion brain MRI study combined with dipyridamole stress. Scand Cardiovasc J. 2021;55:97&#x2013;101. https://doi.org/10.1080/14017431.2020.1821911 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017431.2020.1821911</ArticleId><ArticleId IdType="pubmed">32945202</ArticleId></ArticleIdList></Reference><Reference><Citation>Prodan CI, Batra A, Ungvari Z, Liotta EM. Stringent public health measures during COVID-19 across ischemic stroke care systems: the potential impact of patient perceptions on health care-seeking behaviors. Geroscience. 2022;44:1255&#x2013;62. https://doi.org/10.1007/s11357-022-00566-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00566-8</ArticleId><ArticleId IdType="pubmed">35467316</ArticleId><ArticleId IdType="pmc">9035971</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dusen RA, Abernethy K, Chaudhary N, Paudyal V, Kurmi O. Association of the COVID-19 pandemic on stroke admissions and treatment globally: a systematic review. BMJ Open. 2023;13:e062734. https://doi.org/10.1136/bmjopen-2022-062734 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-062734</ArticleId><ArticleId IdType="pubmed">36931673</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira LC, Ponciano A, Kashani N, Guarda SNF, Hill MD, Smith EE, Stang JM, Viswanathan A, Turner AC, Ganesh A. Stroke metrics during the first year of the COVID-19 pandemic, a tale of two comprehensive stroke centers. Sci Rep. 2023;13:17171. https://doi.org/10.1038/s41598-023-44277-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44277-2</ArticleId><ArticleId IdType="pubmed">37821520</ArticleId><ArticleId IdType="pmc">10567785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojti PP, Szilagyi G, Dobi B, Stang R, Szikora I, Kis B, Kornfeld A, Ovary C, Eross L, Banczerowski P, et al. Impact of COVID-19 on ischemic stroke care in Hungary. Geroscience. 2021;43:2231&#x2013;48. https://doi.org/10.1007/s11357-021-00424-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00424-z</ArticleId><ArticleId IdType="pubmed">34406562</ArticleId><ArticleId IdType="pmc">8371604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng F, Liang J, Li C, Gao D, Xie W. Cognitive decline among older adults with depressive symptoms before and during the COVID-19 pandemic. J Affect Disord. 2024;344:407&#x2013;13. https://doi.org/10.1016/j.jad.2023.10.051 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.10.051</ArticleId><ArticleId IdType="pubmed">37848087</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui T, Mitsuma S, Nagata A, Matsushita S, Asahi T. Accelerated cognitive decline after the COVID-19 pandemic in a community population of older persons with cognitive impairment: a 4-year time series analysis in the Tokyo Metropolis area. Geriatr Gerontol Int. 2023;23:200&#x2013;4. https://doi.org/10.1111/ggi.14543 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.14543</ArticleId><ArticleId IdType="pubmed">36697372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung J, Kim S, Kim B, Kim M, Yang J, Chung D, Won C. Accelerated cognitive function decline in community-dwelling older adults during COVID-19 pandemic: the Korean frailty and aging cohort study (KFACS). Int J Environ Res Public Health. 2022;19(17):10666. https://doi.org/10.3390/ijerph191710666 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191710666</ArticleId><ArticleId IdType="pubmed">36078381</ArticleId><ArticleId IdType="pmc">9518427</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett A, Williams G, Creese B, Hampshire A, Hayman V, Palmer A, Filakovzsky A, Mills K, Cummings J, Aarsland D, et al. Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data. Lancet Healthy Longev. 2023;4:e591&#x2013;9. https://doi.org/10.1016/S2666-7568(23)00187-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(23)00187-3</ArticleId><ArticleId IdType="pubmed">37924840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaheer K, Goncalves B, Ramalingam A, Rabbani NUA, Sayyed R, Nawab A, Puri R, Williams CJ, Mansoor K. Association of new-onset atrial fibrillation with all-cause mortality in COVID-19 patients. Cureus. 2023;15:e49785. https://doi.org/10.7759/cureus.49785 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.49785</ArticleId><ArticleId IdType="pubmed">38058521</ArticleId><ArticleId IdType="pmc">10697182</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaei F, Banga A, Pursell A, Gage A, Pallipamu N, Seri AR, Adhikari R, Kashyap R, Surani S. New-onset atrial fibrillation among COVID-19 patients: a narrative review. World J Crit Care Med. 2023;12:236&#x2013;47. https://doi.org/10.5492/wjccm.v12.i5.236 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5492/wjccm.v12.i5.236</ArticleId><ArticleId IdType="pubmed">38188450</ArticleId><ArticleId IdType="pmc">10768419</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Lehoczki A, Fekete M, Varnai R, Zavori L, Erdo-Bonyar S, Simon D, Berki T, Csecsei P, Ezer E. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01165-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-024-01165-5</ArticleId><ArticleId IdType="pubmed">39115641</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell SJ, Parker K, Lehoczki A, Lieberman D, Partha IS, Scott SJ, Phillips LR, Fain MJ, Nikolich JZ. Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01227-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-024-01227-8</ArticleId><ArticleId IdType="pubmed">38874693</ArticleId></ArticleIdList></Reference><Reference><Citation>Achleitner M, Steenblock C, Danhardt J, Jarzebska N, Kardashi R, Kanczkowski W, Straube R, Rodionov RN, Bornstein N, Tselmin S, et al. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry. 2023;28:2872&#x2013;7. https://doi.org/10.1038/s41380-023-02084-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02084-1</ArticleId><ArticleId IdType="pubmed">37131073</ArticleId><ArticleId IdType="pmc">10152027</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O&#x2019;Keeffe E, Zaporojan L, O&#x2019;Callaghan J, Thomson B, Connolly E, Argue R, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024. https://doi.org/10.1038/s41593-024-01576-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pubmed">38627595</ArticleId><ArticleId IdType="pmc">11088991</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Bonham KS, Anam FA, Walker TA, Faliti CE, Ishii Y, Kaminski CY, Ruunstrom MC, Cooper KR, Truong AD, et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat Commun. 2023;14:4201. https://doi.org/10.1038/s41467-023-40012-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40012-7</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId><ArticleId IdType="pmc">10349085</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Nagy B Jr, R&#xe1;duly AP, M&#xe1;nyin&#xe9; IS, M&#xe1;rtha L, Erd&#x151;si G, Sipka S Jr, Enyedi E, Szab&#xf3; A&#xc1;, P&#xf3;lik Z, Kappelmayer J. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Geroscience. 2022;44(5):2347&#x2013;60. https://doi.org/10.1007/s11357-022-00649-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00649-6</ArticleId><ArticleId IdType="pubmed">36112333</ArticleId><ArticleId IdType="pmc">9483490</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X, Ismail NI, Rahman A, Xu D, Chan RWY, Ong SG, Ong SB. Long COVID-19 and the heart: is cardiac mitochondria the missing link? Antioxid Redox Signal. 2023;38:599&#x2013;618. https://doi.org/10.1089/ars.2022.0126 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2022.0126</ArticleId><ArticleId IdType="pubmed">36053670</ArticleId><ArticleId IdType="pmc">10025846</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Deswal A, Khalid U. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol. 2021;36:234&#x2013;40. https://doi.org/10.1097/HCO.0000000000000832 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000832</ArticleId><ArticleId IdType="pubmed">33394709</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;90. https://doi.org/10.1038/s41591-022-01689-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId><ArticleId IdType="pmc">8938267</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad M, Leon M, Lerman LO, Lerman A. Viral endothelial dysfunction: a unifying mechanism for COVID-19. Mayo Clin Proc. 2021;96:3099&#x2013;108. https://doi.org/10.1016/j.mayocp.2021.06.027 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.06.027</ArticleId><ArticleId IdType="pubmed">34863398</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg A, Pemmasani G, Yandrapalli S, Frishman WH. Cardiovascular and cerebrovascular complications with COVID-19. Cardiol Rev. 2021;29:143&#x2013;9. https://doi.org/10.1097/CRD.0000000000000385 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000385</ArticleId><ArticleId IdType="pubmed">33758123</ArticleId><ArticleId IdType="pmc">8021013</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaster MW, Dey S, Fishkin T, Wang A, Frishman WH, Aronow WS. The impact of long COVID-19 on the cardiovascular system. Cardiol Rev. 2024. https://doi.org/10.1097/CRD.0000000000000654 .</Citation></Reference><Reference><Citation>McLaughlin M, Sanal-Hayes NEM, Hayes LD, Berry EC, Sculthorpe NF. People with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome exhibit similarly impaired vascular function. Am J Med. 2023. https://doi.org/10.1016/j.amjmed.2023.09.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.09.013</ArticleId><ArticleId IdType="pubmed">38104642</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, Schulze A, Evers G, Harmening K, Vink H, Kumpers P, Mohr M, Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. https://doi.org/10.1007/s10456-022-09850-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Vrettou CS, Keskinidou C, Dimopoulou I, Kotanidou A, Orfanos SE. Endotheliopathy in acute COVID-19 and long COVID. Int J Mol Sci. 2023;24(9):8237. https://doi.org/10.3390/ijms24098237 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098237</ArticleId><ArticleId IdType="pubmed">37175942</ArticleId><ArticleId IdType="pmc">10179170</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O&#x2019;Sullivan JM, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;53. https://doi.org/10.1111/jth.15490 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, Bahloul A, Kallel N, Moussa N, Touil I, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8:745758. https://doi.org/10.3389/fcvm.2021.745758 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId><ArticleId IdType="pmc">8670225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Shariff M, Bhat V, DeSimone C, Deshmukh A. Atrial fibrillation after vaccination for COVID-19: analysis of the vaccine adverse event reporting system. J Interv Card Electrophysiol. 2022;65:1&#x2013;2. https://doi.org/10.1007/s10840-022-01263-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-022-01263-4</ArticleId><ArticleId IdType="pubmed">35674855</ArticleId><ArticleId IdType="pmc">9175153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pari B, Babbili A, Kattubadi A, Thakre A, Thotamgari S, Gopinathannair R, Olshansky B, Dominic P. COVID-19 vaccination and cardiac arrhythmias: a review. Curr Cardiol Rep. 2023;25:925&#x2013;40. https://doi.org/10.1007/s11886-023-01921-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-023-01921-7</ArticleId><ArticleId IdType="pubmed">37530946</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>